Seborrheic keratosis is one of the common noncancerous skin growths in older adults. The growths mostly appear on shoulders, back, abdomen, face, chest, and scalp. Cryosurgery is the most preferred method to remove the growth. The method uses liquid nitrogen to freeze off the growth.
Notably, rising technological advancements and increasing participation of market leaders are the key factors driving the seborrheic keratosis market. For instance, in December 2017, Aclaris Therapeutics received FDA approval for Eskata (hydrogen peroxide). Eskata is a high-concentration hydrogen peroxide-based topical solution developed for the treatment of raised seborrheic keratoses.
Various other push factors such as growing demands for aesthetics, increasing government assistance, amendments in the regulatory framework, and rising funding and reimbursement continuously contributing to the growth of the global seborrheic keratosis market. The increasing demands for aesthetics along with the rising prevalence of various skin lesions is making favorable backgrounds for the market to grow.
Despite these drivers, there are some issues associated with seborrheic keratosis market. Some of the challenges in the research and development, the high cost of treatment, side effects associated with surgical & other medical procedures, and poor healthcare system in low and middle-income countries may hinder the growth of the seborrheic keratosis market to an extent.
It is estimated that the seborrheic keratosis market is expected to grow at a CAGR 9.8% during the forecast period of 2017–2023.
Segmentation
The global seborrheic keratosis market is segmented on the basis of type, diagnosis, treatment, and end-user.
On the basis of the type, the market is segmented into common seborrheic keratosis, reticulated seborrheic keratosis or adenoid seborrheic keratosis, stucco keratosis, clonal seborrheic keratosis, irritated seborrheic keratosis, seborrheic keratosis with squamous atypia, melanoacanthoma, dermatosis papulosa nigra, and inverted follicular keratosis. The common seborrheic keratosis is further segmented into basal cell papilloma and solid seborrheic keratosis. The stucco keratosis is further segmented into digitate seborrheic keratosis, hyperkeratotic seborrheic keratosis, serrated seborrheic keratosis, and verrucous seborrheic keratosis.
On the basis of the diagnosis, the market is classified into skin biopsy and others.
On the basis of the treatment, the market is classified as surgical procedures, medication, medical procedures, and others. The surgical procedures segment is further classified into cryosurgery, electrocautery or electrosurgery, curettage, and others. The medical procedures segment is further classified into freezing, tissue scraping, laser therapy, and others.
On the basis of the distribution channels, the market is segmented into hospital, clinics, diagnostic centers, pharmacies, and others.
Key Players
Some of key the players in the global seborrheic keratosis market are Aclaris Therapeutics, Alma Lasers, Angiodynamics, Inc., Apira Science Inc., Becton Dickinson and Company, Biolase Inc., BioLight Technologies LLC, Coherent, Inc., Cutera, Erchonia Corporation, Integra Miltex, IRIDEX Corp., KAI Medical, Lumenis, Quanta Systems S.p.A., Quantumpm, Syneron Medical Ltd., Theralase Inc, THOR Photomedicine, Valeant, and others.
Request Customization
Get a Sample
Get a Sample
Request Customization